Amneal Pharmaceuticals (AMRX) EPS (Basic) Growth (1y) (2019 - 2026)
Amneal Pharmaceuticals (AMRX) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 92.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.15% |
| Mar 31, 2026 | 211.86% |
| Dec 31, 2025 | 335.65% |
| Sep 30, 2025 | 52.00% |
| Jun 30, 2025 | 109.00% |
| Mar 31, 2025 | 129.77% |
| Dec 31, 2024 | 88.01% |
| Sep 30, 2024 | -39.52% |
| Jun 30, 2024 | -29.94% |
| Mar 31, 2024 | -482.34% |
| Dec 31, 2023 | -1,851.06% |
| Sep 30, 2023 | 453.46% |
| Jun 30, 2023 | 109.69% |
| Mar 31, 2023 | -217.34% |
| Dec 31, 2022 | 32.96% |
| Sep 30, 2022 | 37.42% |
| Jun 30, 2022 | -920.33% |
| Mar 31, 2022 | -131.75% |
| Dec 31, 2021 | -107.89% |
| Sep 30, 2021 | 53.34% |